Closing sales leads for pharmaceutical

Effortlessly close more pharmaceutical sales leads with airSlate SignNow's user-friendly solution. Enhance efficiency and drive growth.

airSlate SignNow regularly wins awards for ease of use and setup

See airSlate SignNow eSignatures in action

Create secure and intuitive e-signature workflows on any device, track the status of documents right in your account, build online fillable forms – all within a single solution.

Collect signatures
24x
faster
Reduce costs by
$30
per document
Save up to
40h
per employee / month

Our user reviews speak for themselves

illustrations persone
Kodi-Marie Evans
Director of NetSuite Operations at Xerox
airSlate SignNow provides us with the flexibility needed to get the right signatures on the right documents, in the right formats, based on our integration with NetSuite.
illustrations reviews slider
illustrations persone
Samantha Jo
Enterprise Client Partner at Yelp
airSlate SignNow has made life easier for me. It has been huge to have the ability to sign contracts on-the-go! It is now less stressful to get things done efficiently and promptly.
illustrations reviews slider
illustrations persone
Megan Bond
Digital marketing management at Electrolux
This software has added to our business value. I have got rid of the repetitive tasks. I am capable of creating the mobile native web forms. Now I can easily make payment contracts through a fair channel and their management is very easy.
illustrations reviews slider
Walmart
ExxonMobil
Apple
Comcast
Facebook
FedEx
be ready to get more

Why choose airSlate SignNow

  • Free 7-day trial. Choose the plan you need and try it risk-free.
  • Honest pricing for full-featured plans. airSlate SignNow offers subscription plans with no overages or hidden fees at renewal.
  • Enterprise-grade security. airSlate SignNow helps you comply with global security standards.
illustrations signature

Closing sales leads for pharmaceutical

Are you struggling to close sales leads for pharmaceutical products? airSlate SignNow offers a seamless solution to streamline the signing process and accelerate sales. With our user-friendly platform, you can easily sign and send important documents to potential clients in the pharmaceutical industry.

closing sales leads for pharmaceutical

airSlate SignNow benefits pharmaceutical sales teams by simplifying the document signing process, allowing for quicker turnaround times and increased efficiency. Start using airSlate SignNow today and experience the difference it can make in closing sales leads for pharmaceutical products.

Streamline your sales process with airSlate SignNow and start closing more deals today!

airSlate SignNow features that users love

Speed up your paper-based processes with an easy-to-use eSignature solution.

Edit PDFs
online
Generate templates of your most used documents for signing and completion.
Create a signing link
Share a document via a link without the need to add recipient emails.
Assign roles to signers
Organize complex signing workflows by adding multiple signers and assigning roles.
Create a document template
Create teams to collaborate on documents and templates in real time.
Add Signature fields
Get accurate signatures exactly where you need them using signature fields.
Archive documents in bulk
Save time by archiving multiple documents at once.
be ready to get more

Get legally-binding signatures now!

FAQs online signature

Here is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

Need help? Contact support

Trusted e-signature solution — what our customers are saying

Explore how the airSlate SignNow e-signature platform helps businesses succeed. Hear from real users and what they like most about electronic signing.

Easy to use
5
Jessi Frencken

What do you like best?

It is very easy to use and to customize documents.

Read full review
Super simple and helpful!
5
Austen Gravett

What do you like best?

I love how they have streamlined the entire process and make it easy to use.

Read full review
So far,best document signing software that I've tested
5
Dayna Cooper

What do you like best?

I like that I can create links that I can put into other documents.

Read full review
video background

How to create outlook signature

Two zombies are eating a clown One zombie looks at the other zombie and goes, "does this guy taste funny to you?" What do zombies and sales have in common? They both come back from the dead. Welcome to today's whiteboard wednesday. What we do in sales at DiscoverOrg is regularly run plays and campaigns that have immediate boosts on our pipeline. And three of those plays that we run all involve some form of going back to leads that went dead on us and bringing them back to life. And the really interesting thing is that we find re-livened leads actually outperform our regular leads. Let me explain while I explain these sort of three plays that I think you can be using too. So play number one is we do what we call web form go backs. And web form go backs is when a lead in bounds through our website, we convert them at a 40% rate, we are diligent about following up with these leads. We have an SLA that we call them within two minutes of them filling out the form. If we don't get them on the phone, we shoot them an email and we call them back a few hours later. And then we call them back the next day and the next day. But at a certain point we give up, right, you can only put so much effort into it. However, we do know that there was some interest at this company, they raised their hand for a reason, and we believe that there's a need the company has and that they would benefit from our service. So we don't stop there. We wait 45 days after they in bounded and then we give them over to our outbound SDR team and we treat them as cold leads again, we sort of start from scratch. But the outbound SDRs go after these leads, they go back to them, and what we find is they convert at a 15% rate. Now, 15% is obviously not as good as 40%. But by the time it's in the hands of the outbound team, I mean, when they're cold calling they're going to convert 5%, 6% of the leads that they cold call. And here we give them a pool of leads to call on that they can convert at 15%. So they're happy, they love going after these, the company is happy because we're getting as many of these in bound leads as possible and real opportunities into our pipeline. So lesson number one is, if you're getting any in bound leads through your website, be very diligent about following up with them and then go back to them at some point later if you haven't converted them. That's play number one. Play number two. Similar theme, right? Sort of zombiesque. But we go back to our closed dead opportunities, so closed dead ops. Now for us, a closed dead op is maybe what most of you would call a closed loss op. But it's ops where we didn't lose it to a competitor, we just had no decision or they went dark on us, they just stopped getting back to us for whatever reason. Our account execs eventually give up on those opportunities, they mark them closed dead in our sales force and then they sort of sit there, we're going to get them back to marketing, they're going to nurture them, but there's no real manual effort or activity put into those anymore. For a period of about one year, or even six months. After a certain period of time what we do is we take all of our closed dead ops over the last six months or the last year and we swap them amongst account execs. So if we have Johnny, an account exec, and Jane, an account exec, we're going to swap their closed dead ops. And then Johnny's team is going to go after Jane's closed dead ops, and Jane's team is going to go after Johnny's. And what we find on new clients, is on average they have average 1.6 new opportunities tied to their account by the time we bring them on as a client. I think that stat is really interesting and really surprising. What it tells us is that, on average, our customers need to evaluate DiscoverOrg, go through a sales cycle, come to no decision, but now they're familiar with us, they're more comfortable with us, they're getting used to the price point that we're at. And six months later or a year later, when we go back to them and they re-evaluate DiscoverOrg for the second time in the second new business opportunity, they are far more likely to buy. Our win rate on companies that we re-engage and get the second opportunity with is much, much higher than our win rate on companies where we're going through our first opportunity with them. So lesson number two, similar to lesson number one, is go back to companies that you had previously identified were good fits, that had previously gone through a sales cycle with you, that were qualified, and find out is there new leadership there? Are there other stakeholders at the company we should be engaging? Or should we just go back to our main point of contact we had the first time around and is the timing better now? And are they more comfortable with the thought of investing in your solution? This is my favorite play we run on the sales team. Play number three is what we call re-livens. And that's a very zombiesque word. Re-livens are pretty similar to closed dead ops, they just happen earlier. So if I'm an account executive at DiscoverOrg and I have an active opportunity that I think is a great fit but that opportunity goes dark on me. Maybe I had a scheduled follow-up call and the prospect didn't show up to it, and so I send them some value pieces and try to nurture them and re-engage them. But I do that for a week then I sort of give up because I've got 100 open opportunities and I don't have the bandwidth to continually chase down someone who's gone dark on me. So what I'm going to do, I'm going to pass that back to my SDR and say, "SDR, go re-engage my main point of contact by calling them repeatedly, more often than I could, sending them value emails more often than I could, or either go above them or around them to other stakeholders in the organization." And just like closed dead, when we re-liven opportunities, those win at a much higher rate than opportunities that are just sort of going through our new process. So to pull it all together, what did we learn? We learned that closed dead opportunities, leads that have gone dead and cold on us, are sometimes the best performing leads. We know that these are companies that had an interest in our service at one point, that had expressed a need, a problem that we can help solve, and it would be a shame not to fully capitalize on those. So we want to go back to those leads, we want to go back to those opportunities and bring them back to life. And these are three plays that we're constantly running in the sales team to get short term gains and immediate gains to our pipeline. This is something I think about as a sales leader all the time. How can I impact sales not three months down the road, six months down the road, what can I do right now to impact sales this month, this quarter? And so we'd love to hear from you. What are the plays that you're running in your sales team to boost your pipeline and get immediate results? Please comment on the video below. Share it, let us know your thoughts, we want to hear from you.

Show more
be ready to get more

Get legally-binding signatures now!

Sign up with Google